APVO - Aptevo Therapeutics Inc

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
1.61 -0.04 (-2.48%)	---	0.0 (0.0%)	-0.01 (-0.58%)	0.02 (1.24%)	-0.04 (-2.17%)	-0.01 (-0.58%)	-0.01 (-0.58%)

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -8.4
Diluted EPS:: -8.4
Basic P/E:: -0.1869
Diluted P/E:: -0.1869
RSI(14) 1m:: 50.0
VWAP:: 1.57
RVol:: 0.0882

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	1.67 +0.03 (+1.52%)	Oct 15 09:43
10m	Price increase 10m	1.67 +0.05 (+3.42%)	Oct 15 09:37
1m	Price increase 1m	1.64 +0.02 (+1.51%)	Oct 15 09:33
1m	Price decrease 1m	1.56 -0.02 (-1.27%)	Oct 15 04:22
1m	Price decrease 1m	1.55 -0.02 (-1.27%)	Oct 15 04:11